[Multidrug resistance: a century after "606"].
Llorente
L
L
lllyrp@quetzal.innsz.mx
Richaud-Patin
Y
Y
Jakez-Ocampo
J
J
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D000328:Adult; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001153:Arsphenamine / Q000266:history; D001327:Autoimmune Diseases / Q000188:drug therapy*; D002121:Calcium Channel Blockers / Q000494:pharmacology / Q000627:therapeutic use*; D004351:Drug Resistance; D018432:Drug Resistance, Multiple; D004357:Drug Synergism; D005260:Female; D019450:Genes, MDR; D049672:History, 19th Century; D049673:History, 20th Century; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use; D012216:Rheumatic Diseases / Q000188:drug therapy; D014700:Verapamil / Q000494:pharmacology / Q000627:therapeutic use*
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000893:Anti-Inflammatory Agents; D002121:Calcium Channel Blockers; D001153:Arsphenamine; D014700:Verapamil; D011241:Prednisone